Home Cardiac arrest EMS volume doesn't affect traumatic arrest outcomes
Cardiac arrest
EMS volume doesn't affect traumatic arrest outcomes
Impact of emergency medical services volume on outcomes and management in prehospital traumatic cardiac arrest: a retrospective cohort study
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine · Added 20 May 2026
Retrospective cohort examining whether higher EMS encounter volume is associated with better management and outcomes in prehospital traumatic cardiac arrest.
- Study type
- Registry
- Design
- Retrospective multicentre registry cohort (French RéAC)
- Participants
- 6,263 traumatic OHCA cases among 151,658 OHCAs, 175 EMS bases
- Main finding
- No association between EMS TCA volume and survival to hospital admission (OR 1.00; 95% CI 0.99–1.01), ROSC, 30-day survival (OR 1.01; 0.98–1.05) or favourable neurological outcome
- Caveat
- Retrospective registry data from a physician-staffed French system; limited generalisability
- Bottom line
- Context only
Learning goal
Understand how service volume and system structure influence prehospital traumatic cardiac arrest outcomes across different models of care.
More
- Topic: Cardiac arrest
- Daily scan: 20 May 2026
Related papers on Cardiac arrest
-
System failure drives poor OHCA outcomes in India
This commentary argues that poor resuscitation outcomes in India are driven by prehospital system failures rather than individual provider limitations, highlighting the need for structural reforms in emergency response infrastructure and training.
-
AED use varies by race and geography
Analysis of AED deployment patterns during EMS encounters revealing racial and geographic differences in defibrillator access and application.
-
Poor Utstein reporting in traumatic OHCA studies
Scoping review evaluated the extent to which prehospital traumatic cardiac arrest studies report Utstein-recommended variables to improve data standardization.
-
DSED use rising but still low after DOSE VF
Nationwide observational study examined trends in DSED use for refractory VF before and after publication of the DOSE VF trial.